Verition Fund Management’s Celularity CELU Stock Holding History

Verition Fund Management’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,281	Closed	-$30K	–	2211
2022 Q3	$30K	Hold	1,281	–	–	﹤0.01%	2742
2022 Q2	$44K	Sell	1,281 -3,719	-74%	-$302K	﹤0.01%	2160
2022 Q1	$436K	Hold	5,000	–	–	0.01%	1971
2021 Q4	$256K	Hold	5,000	–	–	﹤0.01%	2086
2021 Q3	$354K	Hold	5,000	–	–	﹤0.01%	1379
2021 Q2	$509K	Sell	5,000 -5,000	-50%	-$507K	﹤0.01%	1084
2021 Q1	$1.01M	Buy	10,000 +5,000	+100%	+$512K	0.01%	606
2020 Q4	$550K	Hold	5,000	–	–	﹤0.01%	646
2020 Q3	$525K	Sell	5,000 -5,000	-50%	-$518K	0.01%	564
2020 Q2	$1.02M	Sell	10,000 -5,000	-33%	-$496K	0.03%	408
2020 Q1	$1.47M	Buy	+15,000	New	+$1.48M	0.06%	201

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Verition Fund Management's CELU Position: Q4 2022 in Review

Verition Fund Management sold out of Celularity (CELU) in Q4 2022, closing a stake of 1,281 shares — an estimated $30K sold.

Verition Fund Management first reported a position in CELU in Q1 2020 and held it in 11 quarters. The position peaked at $1.47M in Q1 2020. 73 funds tracked by Wall St. Rank hold CELU as of Q4 2022.

Verition Fund Management reported no remaining Celularity position as of Q4 2022 after selling out during the quarter.
Verition Fund Management sold 1,281 Celularity shares in Q4 2022, an estimated $30K.
Verition Fund Management first reported a position in Celularity in Q1 2020 and held it in 11 quarters.
Verition Fund Management's Celularity position peaked at $1.47M in Q1 2020.
73 funds tracked by Wall St. Rank held Celularity as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.